Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02715778 · ClinicalTrials.gov registry record
Translational Investigation of Gestational Environment on Neurobehavioral Function in Children
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 95
- Enrollment target
NCT02715778: Completed study, sponsored by Massachusetts General Hospital.
NCT02715778 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 95 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02715778 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
Although the last decade has brought major advances with respect to our knowledge of certain risks associated with fetal exposure to psychiatric medications, critical information regarding the long-term neurobehavioral impact of fetal exposure is lacking. With a prevalence rate of selective serotonin reuptake inhibitor (SSRI) use across pregnancy in Western countries noted to be as high as 5-8%, this study aims to close the gap in knowledge regarding long-term neurobehavioral sequelae of in utero exposure to this class of antidepressants. Importantly, the assessment of the impact of antenatal psychotropic medication use must be conducted with an appreciation of the potential direct and indirect effects of maternal psychiatric illness during pregnancy and throughout childhood. The outcomes of this study will help to inform the care of reproductive age women treated with psychiatric medications as they, along with the clinicians prescribing for them, weigh the relative risks of using these agents during pregnancy.
Primary Outcome
Further information on CANTAB available at: http://www.cambridgecognition.com/academic/crs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2016-02 |
| Est. Completion | 2019-06 |
What the finished NCT02715778 record still lists
NCT02715778 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 95 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02715778 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02715778 about?
NCT02715778 is a clinical study titled "Translational Investigation of Gestational Environment on Neurobehavioral Function in Children". Although the last decade has brought major advances with respect to our knowledge of certain risks associated with fetal exposure to psychiatric medications, critical information regarding the long-term neurobehavioral impact of fetal exposure is lacking. With a prevalence rate of selective serotoni...
What is the current status of trial NCT02715778?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2016-02. Estimated completion is 2019-06.
Who is sponsoring clinical trial NCT02715778?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03339128 · 95 participants · Phase 2
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children
- NCT03509961 · 95 participants · Phase 2
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL
- NCT03694756 · 95 participants · NA
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer
- NCT04206215 · 95 participants · NA
Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia